AVITA Medical, Inc. (ASX:AVH – Get Free Report) insider Robert McNamara bought 11,000 shares of the firm’s stock in a transaction on Friday, March 7th. The stock was bought at an average price of A$8.30 ($5.25) per share, with a total value of A$91,300.00 ($57,784.81).
Robert McNamara also recently made the following trade(s):
- On Friday, February 21st, Robert McNamara acquired 10,000 shares of AVITA Medical stock. The shares were acquired at an average price of A$10.09 ($6.39) per share, with a total value of A$100,900.00 ($63,860.76).
AVITA Medical Stock Performance
The company has a quick ratio of 9.32, a current ratio of 8.18 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $226.55 million, a PE ratio of -5.55 and a beta of 1.54.
About AVITA Medical
AVITA Medical, Inc, together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions.
Further Reading
- Five stocks we like better than AVITA Medical
- Financial Services Stocks Investing
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What is a Bond Market Holiday? How to Invest and Trade
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- What is a buyback in stocks? A comprehensive guide for investors
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for AVITA Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA Medical and related companies with MarketBeat.com's FREE daily email newsletter.
